The Evidence

What brain imaging really shows in MCS — and what a scan cannot tell you

Brain imaging finds real, repeated differences in how people with MCS process sensory information. That is objective evidence, visible on a scan, produced by equipment that cannot be talked into a result — and it is the direct answer to anyone who says this is all in your head. Something measurable is happening in the nervous system of a person with MCS that is not happening in a control. What a scan cannot do is settle where that change came from, because every perception and every symptom involves the brain; imaging shows altered function, not its origin. Anyone citing these scans as proof of psychological causation has the logic backwards: an organ working differently is a physical finding.

Brain studies add objective evidence that sensory processing is altered in chemical intolerance. They do not identify a single cause, prove psychological origin, or give us a diagnostic MCS scan.

What brain imaging can actually tell us

Multiple Chemical Sensitivity is often described as if the central question were whether the brain is involved. That is no longer a useful question. The brain is involved in every sensory experience, every autonomic response, every learned association, and every perception of threat. The more useful question is whether people with chemical intolerance show reproducible differences in how the brain processes environmental stimuli - and, if so, what those differences mean.

A 2019 review identified 23 experimental human studies involving chemical intolerance or MCS and neurological responses or brain imaging after exposure to odorous or pungent substances. Across that heterogeneous literature, the reviewers found consistent evidence that sensory information was processed differently in chemically intolerant subjects than in healthy controls, particularly in limbic and related cortical networks. That is meaningful evidence of altered neurological processing. It is not, by itself, a diagnosis of cause.

The pattern is real; the interpretation is harder

The imaging literature includes SPECT, PET, functional MRI and other neurophysiological methods. Individual studies have reported differences in cerebral blood flow, olfactory processing, limbic activation, prefrontal responses and network behavior during or after chemical stimulation. The exact pattern is not identical from study to study. Different case definitions, trigger substances, imaging methods, exposure protocols and sample sizes make a single universal "MCS brain scan" impossible to claim.

That variability should not be used to erase the finding. A heterogeneous literature can still show a recurring signal: people classified as chemically intolerant often process sensory exposure differently from comparison subjects. The 2019 review concluded that altered neurological processing of sensory information was consistently documented, while also calling for better neurophysiological research to determine how those differences relate to symptoms.

A different brain scan is a physical finding, not a psychological one

Brain imaging is sometimes mishandled in two opposite directions. One side says, "The scan is different, therefore MCS is proven to be a toxic brain injury." The other says, "The limbic system is active, therefore the illness is psychological." Neither conclusion follows.

Brains change after injury, infection, chronic pain, repeated sensory stimulation, fear learning, trauma, rehabilitation and ordinary learning. Imaging identifies activity, blood flow or network differences; it does not automatically identify the event that created those differences. The presence of limbic or prefrontal changes therefore does not tell us whether environmental exposure, peripheral sensory sensitization, autonomic dysregulation, conditioning, inflammation, repeated illness experiences or several of these together came first.

This is why our language stays disciplined: brain involvement is biological. Psychological processes can modify brain function, but a neurological finding is not evidence that conscious or subconscious thought created consensus-defined MCS.

Where predictive coding belongs - and where it does not

Modern predictive-processing models offer a useful way to think about how an established sensory disorder might be amplified. The brain continuously combines incoming signals with prior experience and expectation. Once a person has repeatedly become ill around a particular odor or environment, learned prediction may change attention, autonomic output and symptom intensity.

That possibility belongs in the MCS model as a modifier and potential maintenance mechanism. It does not establish that prediction initiated the illness. The same rule applies to "neurotags," somatic tracking and other neuroplastic concepts: they may help explain why a response becomes easier to trigger or harder to extinguish without proving that thought was the original cause.

What the registry is answering

The Canary Registry can help connect imaging findings to chronology and phenotype. It can identify people whose illness began before they recognized an environmental cause, people with rapid versus delayed reactions, people with strong autonomic features, people with prior TBI or PTSD, people with MCAS/POTS overlap, and people who later regained substantial tolerance.

Those phenotypes could then be recruited into imaging and neurophysiology studies. The important next step is not simply to show that an MCS brain looks different during exposure. It is to ask whether different MCS subgroups show different neural patterns, whether those patterns change during remission or restored tolerance, and whether peripheral sensory or autonomic changes precede the central response.

Where we stand

Brain imaging supports the conclusion that chemical intolerance involves altered neurological processing. It does not establish one universal brain signature and it does not tell us, by itself, what caused the disorder.

The brain is part of the MCS biology, not evidence against it. The research task is to determine how central processing interacts with sensory nerves, autonomic regulation, immune signaling, prior exposure and learned amplification - and which of those changes are reversible when tolerance returns.

We followed the evidence. Here’s where it leads →

Sources

Sources

1Hillert L, Musabasic V, Berglund H, Ciumas C, Savic I. Odor processing in multiple chemical sensitivity. Human Brain Mapping. 2007;28(3):172–182. PMID: 16767766. DOI: 10.1002/hbm.20266.
2Orriols R, Costa R, Cuberas G, Jacas C, Castell J, Sunyer J. Brain dysfunction in multiple chemical sensitivity. Journal of the Neurological Sciences. 2009;287:72-78.
3Viziano A, Micarelli A, Pasquantonio G, Della-Morte D, Alessandrini M. Perspectives on multisensory perception disruption in idiopathic environmental intolerance: a systematic review. International Archives of Occupational and Environmental Health. 2018;91:923–935. DOI: 10.1007/s00420-018-1346-z.
4Rossi S, Pitidis A. Multiple Chemical Sensitivity: Review of the State of the Art in Epidemiology, Diagnosis, and Future Perspectives. Journal of Occupational and Environmental Medicine. 2017;60(2):138-146. PMID: 29111991. DOI: 10.1097/JOM.0000000000001215.
5Pitron V, Köteles FG, Nordin S, Haanes JV, Hillert L, Léger D, Lemogne C, Szemerszky R, van Kamp I, van Thriel C, Witthöft M, Van den Bergh O. Multiple Chemical Sensitivity: Catching up to what kind of science? Neuroscience & Biobehavioral Reviews. 2024;157:105524. PMID: 38154656. DOI: 10.1016/j.neubiorev.2023.105524.
61. Azuma K, Uchiyama I, Tanigawa M, et al. Chemical intolerance: involvement of brain function and networks after exposure to extrinsic stimuli perceived as hazardous. Environ Health Prev Med. 2019;24:61. PMCID: PMC6806489. https://pmc.ncbi.nlm.nih.gov/articles/PMC6806489/
← Back to MCSDisability.com
↑